John Coustas - 18 Mar 2026 Form 3 Insider Report for Danaos Corp (DAC)

Role: Chief Executive Officer, Director
Signature: /s/ Evangelos Politis, Attorney-in-Fact
Issuer symbol: DAC
Transactions as of: 18 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Mar 2026, 10:10:45 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Coustas John	Chief Executive Officer, Director	14 AKTI KONDYLI, 185 45 PIRAEUS, GREECE	/s/ Evangelos Politis, Attorney-in-Fact	18 Mar 2026	0001389183

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DAC	Common Stock						9,538,502	18 Mar 2026	By Danaos Investment Limited as Trustee of the 883 Trust	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held indirectly through Danaos Investment Limited ("DIL") as Trustee of the 883 Trust. The beneficiaries of the 883 Trust are Dr. Coustas and members of his family. The board of directors of DIL consists of five members, none of whom are beneficiaries of the 883 Trust or members of the Coustas family, and has voting and dispositive control over the shares held by the 883 Trust. Dr. Coustas has certain powers to remove and replace DIL as trustee of the 883 Trust. Dr. Coustas disclaims beneficial ownership of such shares purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that Dr. Coustas is a beneficial owner of the shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Content

Shares held indirectly through Danaos Investment Limited ("DIL") as Trustee of the 883 Trust. The beneficiaries of the 883 Trust are Dr. Coustas and members of his family. The board of directors of DIL consists of five members, none of whom are beneficiaries of the 883 Trust or members of the Coustas family, and has voting and dispositive control over the shares held by the 883 Trust. Dr. Coustas has certain powers to remove and replace DIL as trustee of the 883 Trust. Dr. Coustas disclaims beneficial ownership of such shares purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that Dr. Coustas is a beneficial owner of the shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Remarks:

Exhibit 24 - Power of Attorney